Rising cases fan testing debate; Fauci optimistic on vaccine timeline
Global coronavirus diagnoses topped 9 million, underscoring the difficulties governments around the world are having
vaccine
Our coronavirus vaccine is aiming for a 70% success rate
Johnson & Johnson (JNJ) is setting a relatively high bar for its experimental coronavirus vaccine,
Peter Navarro says the manufacturing of a coronavirus vaccine will be swift
Entities around the world are locked in a race to develop a vaccine for the
US reopening dogged by fears of new wave as pharma presses on with vaccine
A sudden spike in new coronavirus cases across key U.S. states put markets back on
Reopenings continue as virus counts spike in key states; J&J ramps up vaccine push
A jump in the coronavirus counts of California and southern states fanned fears of a
Payrolls spark hope for a fast rebound as Novavax gets a boost in vaccine race
Stunning news that the U.S. economy added over 2.5 million jobs in May fanned hopes
HHS moves to boost coronavirus case tracking; AstraZeneca expands vaccine deals
The U.S. Health and Human Services department released new guidelines on Thursday to improve tracking
How Novavax is pulling out all the stops to produce a coronavirus vaccine by next year
Novavax (NVAX), the latest company to enter the increasingly crowded field to produce a coronavirus
Novartis enters vaccine race as reopenings, testing efforts ramp up
Pharmaceutical companies on Thursday continued their pursuit of a breakthrough in the fight against the
12-18 month coronavirus vaccine timeline ‘is extremely optimistic’
As the fallout from the coronavirus pandemic continues, the search for a vaccine is not
Novavax begins vaccine trials; Brazil reports second-highest number of cases in world
Eased lockdowns and lifted restrictions have placed significant pressure on the global drug pipeline. The